News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
HBM Healthcare Investments (Cayman) Ltd.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.4% stake in IO Biotech, Inc. |
| 07/02/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 6.7% stake in Ambrx Biopharma, Inc. |
| 03/22/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.2% stake in Harmony Biosciences Holdings, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.2% stake in Galecto, Inc. |
| 12/28/2020 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.8% stake in BioAtla, Inc. |
| 11/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/01/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 9% stake in Y-mAbs Therapeutics, Inc. |
| 09/27/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.3% stake in Principia Biopharma Inc. |
| 03/16/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.4% stake in ARMO BioSciences, Inc. |
| 03/13/2017 |
SC 13G
| ANAPTYSBIO INC reports a 4.7% stake in AnaptysBio, Inc. |
| 03/13/2017 |
SC 13G
| ObsEva SA reports a 8.1% stake in ObsEva SA |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/16/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2006 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 13.7% stake in Micrus Endovascular Corp. |
| 02/14/2006 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 5.5% stake in Icagen, Inc. |
| 09/01/2005 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 18% stake in Adherex Technologies Inc. |
| 06/01/2005 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 5.6% stake in Barrier Therapeutics, Inc. |
| 03/25/2005 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 5.2% stake in DOV Pharmaceutical, Inc. |
| 03/14/2005 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 16.3% stake in Aspreva Pharmaceuticals Corporation |
| 02/14/2005 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 2.8% stake in Corgentech Inc. |
| 05/18/2004 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 6.7% stake in Anadys Pharmaceuticals, Inc. |
| 02/17/2004 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 3.7% stake in DepoMed, Inc. |
| 02/17/2004 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 6.9% stake in Inspire Pharmaceuticals, Inc. |
| 02/17/2004 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 8.2% stake in Rigel Pharmaceuticals, Inc. |
| 07/31/2003 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 5.2% stake in Inspire Pharmaceuticals, Inc. |
| 07/07/2003 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 9.1% stake in Rigel Pharmaceuticals, Inc. |
| 05/13/2003 |
SC 13G
| HBM BIOVENTURES CAYMAN LTD reports a 7.9% stake in DepoMed, Inc. |
|
|